Crossmark

Physiologically-based pharmacokinetic model for predicting drug-drug interactions perpetrated by posaconazole in healthy subjects with normal weight and obesity: Concomitant use and washout

Crossref DOI link: https://doi.org/10.1007/s10928-025-09983-6

Published Online: 2025-07-18

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bruno, Christopher D.

Elmokadem, Ahmed

Greenblatt, David J.

Chow, Christina R.
Funding

Funding for this research was provided by:

National Institutes of Health (UM1TR004398)
License Information

Text and Data Mining valid from 2025-07-18

Version of Record valid from 2025-07-18
More Information

Article History

Received: 28 January 2025

Accepted: 6 May 2025

First Online: 18 July 2025

Declarations

:

: CDB and CRC are employees of Emerald Lake Safety, LLC. DJG is supported in part by grant UM1 TR004398 from the National Institutes of Health, Department of Health and Human Services. The BOW-001 and BOW-002 studies were funded by Emerald Lake Safety, LLC and followed ethical guidelines as described in the original study publications.

Document is current

Any future updates will be listed below